Show all results

Consolidated Income Statement1

12.34 KBEXCEL
€ million Note 2019 2018
Net sales 11 16,152 14,836
Cost of sales 12 -6,006 -5,382
Gross profit   10,145 9,454
       
Marketing and selling expenses 13 -4,576 -4,396
Administration expenses   -1,154 -1,183
Research and development costs 14 -2,268 -2,227
Impairment losses and reversals of impairment losses on financial assets (net) 42 -8 27
Other operating income 15 715 627
Other operating expenses 16 -735 -575
Operating result (EBIT)2   2,120 1,727
       
Finance income 40 97 77
Finance costs 40 -481 -343
Profit before income tax   1,735 1,461
       
Income tax 17 -440 -368
Profit after tax from continuing operations   1,296 1,093
Profit after tax from discontinued operation 5 28 2,303
Profit after tax   1,324 3,396
thereof: attributable to shareholders of Merck KGaA, Darmstadt, Germany (net income)   1,320 3,374
thereof: attributable to non-controlling interests 34 3 22
       
Earnings per share (in €) 8    
Basic   3.04 7.76
from continuing operations   2.97 2.51
from discontinued operation   0.07 5.25
Diluted   3.04 7.76
from continuing operations   2.97 2.51
from discontinued operation   0.07 5.25
1 Previous year’s figures have been adjusted, see Note (45) “Effects from new accounting standards and other presentation changes”.
2 Not defined by International Financial Reporting Standards (IFRSs).